Get App

Merck to supply up to 1 mln courses of COVID-19 pill to Canada

The government of Canada has secured access to 500,000 courses in 2022, with options for up to 500,000 more, pending Health Canada's approval, the company said.
  • Published On Dec 4, 2021 at 12:01 PM IST
Merck & Co said on Friday it would supply the Canada with up to 1 million courses of molnupiravir, its experimental oral antiviral medicine for the treatment of COVID-19.

The government of Canada has secured access to 500,000 courses in 2022, with options for up to 500,000 more, pending Health Canada's approval, the company said.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Amy Caren Daniel)

  • Published On Dec 4, 2021 at 12:01 PM IST

Comments

comment
What are your thoughts?
Comment Now Read Comment (1)

Join the community of 2M+ industry professionals.

Subscribe to Newsletter to get latest insights & analysis in your inbox.

All about ETHealthworld industry right on your smartphone!

image